Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and

Mahdi Ahmadi1, Monireh Mahmoodi2, Maryam Shoaran3

  • 1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 5665665811, Iran.

Insights

Mesenchymal stem cell-derived exosomes (MSCs-Exo) show dual roles in cancer, potentially promoting or suppressing tumors. Further research and standardization are crucial for their therapeutic application in cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biotechnology

Background:

  • Metastatic cancers cause over 8 million deaths annually, necessitating novel therapeutic strategies.
  • Mesenchymal stem cells (MSCs) and their derived exosomes (MSCs-Exo) are emerging as potential cancer therapeutics.
  • The precise role of MSCs-Exo in tumor progression remains controversial, with evidence suggesting both pro- and anti-tumorigenic effects.

Purpose of the Study:

  • To review the multifaceted roles of MSCs-Exo in tumor progression, including effects on growth, metastasis, immunity, angiogenesis, and drug resistance.
  • To explore the potential of MSCs-Exo as standalone therapeutics and drug delivery systems for cancer treatment.
  • To highlight the importance of engineering MSCs-Exo for targeted cancer therapy and discuss challenges for clinical translation.

Main Methods:

  • Literature review of studies investigating the interaction between MSCs-Exo and various cancers.
  • Analysis of evidence for both tumor-promoting and tumor-suppressing mechanisms mediated by MSCs-Exo.
  • Examination of current strategies for MSCs-Exo isolation, characterization, loading, and engineering.

Main Results:

  • MSCs-Exo exhibit complex regulatory functions in cancer, influencing tumor growth, metastasis, immune evasion, angiogenesis, and drug resistance.
  • Contradictory findings exist regarding MSCs-Exo's impact on tumors, underscoring the need for further clarification.
  • Engineering MSCs-Exo offers a promising approach to enhance their antitumor efficacy through targeted delivery.

Conclusions:

  • MSCs-Exo play pivotal roles in tumor progression, presenting both challenges and opportunities for cancer therapy.
  • Harnessing MSCs-Exo as drug delivery vehicles or standalone agents holds significant therapeutic promise.
  • Standardization of isolation, characterization, and engineering methods is essential for the successful clinical implementation of MSCs-Exo-based cancer therapies.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K